Literature DB >> 19582454

Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.

Masataka Hosoi, Go Yamamoto, Yoichi Imai, Mineo Kurokawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19582454     DOI： 10.1007/s00277-009-0783-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.

Authors:  Samuel Singer; Christian Grommes; Anne S Reiner; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Oncologist       Date:  2015-06-01

2.  Posterior Reversible Encephalopathy Syndrome Secondary to R-CHOP Chemotherapy Regimen.

Authors:  Selim Jennane; El Mehdi Mahtat; Mounir Ababou; Hicham El Maaroufi; Kamal Doghmi
Journal:  Cureus       Date:  2022-05-14

3.  Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse.

Authors:  Sarah A Morrow; Robina Rana; Donald Lee; Terri Paul; Jeffrey L Mahon
Journal:  Case Rep Neurol Med       Date:  2015-05-26

4.  Acute Respiratory Distress Syndrome and Posterior Reversible Encephalopathy Syndrome following Rituximab Therapy.

Authors:  Katrina E Wardrope; Lynn Manson; Wendy Metcalfe; Eoin D O Sullivan
Journal:  Case Rep Nephrol Dial       Date:  2016-02-24

5.  Mepolizumab-Induced Posterior Reversible Encephalopathy Syndrome (PRES), a new patient report.

Authors:  Vikram V Puram; Dana Ghazaleh; Apameh Salari; Kaci McCleary; Gerald Moriarty; Kendall Nichols; Malik Ghannam; Kevin Brown; Brent Berry
Journal:  BMC Neurol       Date:  2022-08-25       Impact factor: 2.903
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.